Mettler-Toledo International (NYSE:MTD – Get Free Report) and Sight Sciences (NASDAQ:SGHT – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, analyst recommendations and risk.
Institutional & Insider Ownership
95.1% of Mettler-Toledo International shares are held by institutional investors. Comparatively, 55.5% of Sight Sciences shares are held by institutional investors. 0.7% of Mettler-Toledo International shares are held by insiders. Comparatively, 28.9% of Sight Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Profitability
This table compares Mettler-Toledo International and Sight Sciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Mettler-Toledo International | 21.59% | -495.07% | 25.47% |
| Sight Sciences | -49.67% | -55.72% | -31.81% |
Valuation & Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Mettler-Toledo International | $4.03 billion | 6.74 | $869.19 million | $42.12 | 31.80 |
| Sight Sciences | $77.36 million | 2.86 | -$38.43 million | ($0.75) | -5.45 |
Mettler-Toledo International has higher revenue and earnings than Sight Sciences. Sight Sciences is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of current ratings and target prices for Mettler-Toledo International and Sight Sciences, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Mettler-Toledo International | 0 | 6 | 7 | 0 | 2.54 |
| Sight Sciences | 1 | 3 | 5 | 0 | 2.44 |
Mettler-Toledo International currently has a consensus target price of $1,459.58, indicating a potential upside of 8.96%. Sight Sciences has a consensus target price of $8.31, indicating a potential upside of 103.24%. Given Sight Sciences’ higher probable upside, analysts clearly believe Sight Sciences is more favorable than Mettler-Toledo International.
Volatility & Risk
Mettler-Toledo International has a beta of 1.43, meaning that its stock price is 43% more volatile than the S&P 500. Comparatively, Sight Sciences has a beta of 2.5, meaning that its stock price is 150% more volatile than the S&P 500.
Summary
Mettler-Toledo International beats Sight Sciences on 10 of the 14 factors compared between the two stocks.
About Mettler-Toledo International
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company’s retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.
About Sight Sciences
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
